Alissa J Roberts1, Hao Bao2, Pingping Qu2, Ashley Moss3, Grace Kim4, Joyce P Yi-Frazier2, Catherine Pihoker4, Faisal Malik4. 1. Department of Pediatrics, University of Washington, WA, USA; Seattle Children's Research Institute, WA, USA. Electronic address: Alissa.Roberts@seattlechildrens.org. 2. Seattle Children's Research Institute, WA, USA. 3. Department of Psychiatry and Behavioral Sciences, University of Washington, WA, USA. 4. Department of Pediatrics, University of Washington, WA, USA; Seattle Children's Research Institute, WA, USA.
Abstract
BACKGROUND: Screening for mental health comorbidities is recommended in adolescents and young adults (AYAs) with diabetes. There is a paucity of data on mental health comorbidities in AYAs with type 2 diabetes (T2D). OBJECTIVE: To assess rates of depression, suicidal ideation, and diabetes distress (DD) in AYAs with T2D overall and by sociodemographic and clinical factors. METHODS: AYAs with T2D ages 13-21 years seen in a pediatric diabetes clinic between March 2018 and June 2019 completed the Patient Health Questionnaire-9 (PHQ-9) for depression screening and the Problem Areas in Diabetes - teen version (PAID-T) survey to assess DD. Chi-square tests were used to assess whether rates of depression and DD were associated with participant characteristics. RESULTS: The sample consisted of 64 AYAs with T2D (58% female, mean age 15.8 ± 2.0 years, mean HbA1c 8.3% ± 2.6%, mean BMI z-score 2.2 ± 0.6, 59% on insulin). Overall, 31% of participants had high depression and/or DD. Twenty-two percent of participants reported high depressive symptoms and 9% endorsed suicidal ideation on the PHQ-9. There were no differences in rates of depression by sociodemographic factors. Twenty-three percent of participants reported high DD. Rates of DD were higher among those on insulin (p = 0.014) and on public health insurance (p = 0.014). CONCLUSIONS: Almost 1 in 3 AYAs with T2D endorsed depression and/or DD. Our findings support the importance of mental health screening in AYAs with T2D, as well as the need for strategies to address psychological comorbidities in this population.
BACKGROUND: Screening for mental health comorbidities is recommended in adolescents and young adults (AYAs) with diabetes. There is a paucity of data on mental health comorbidities in AYAs with type 2 diabetes (T2D). OBJECTIVE: To assess rates of depression, suicidal ideation, and diabetes distress (DD) in AYAs with T2D overall and by sociodemographic and clinical factors. METHODS: AYAs with T2D ages 13-21 years seen in a pediatric diabetes clinic between March 2018 and June 2019 completed the Patient Health Questionnaire-9 (PHQ-9) for depression screening and the Problem Areas in Diabetes - teen version (PAID-T) survey to assess DD. Chi-square tests were used to assess whether rates of depression and DD were associated with participant characteristics. RESULTS: The sample consisted of 64 AYAs with T2D (58% female, mean age 15.8 ± 2.0 years, mean HbA1c 8.3% ± 2.6%, mean BMI z-score 2.2 ± 0.6, 59% on insulin). Overall, 31% of participants had high depression and/or DD. Twenty-two percent of participants reported high depressive symptoms and 9% endorsed suicidal ideation on the PHQ-9. There were no differences in rates of depression by sociodemographic factors. Twenty-three percent of participants reported high DD. Rates of DD were higher among those on insulin (p = 0.014) and on public health insurance (p = 0.014). CONCLUSIONS: Almost 1 in 3 AYAs with T2D endorsed depression and/or DD. Our findings support the importance of mental health screening in AYAs with T2D, as well as the need for strategies to address psychological comorbidities in this population.
Authors: LaRita C Jones; Sylvie Mrug; Marc N Elliott; Sara L Toomey; Susan Tortolero; Mark A Schuster Journal: Acad Pediatr Date: 2017-02-12 Impact factor: 3.107
Authors: Jenna B Shapiro; Anthony T Vesco; Lindsey E G Weil; Meredyth A Evans; Korey K Hood; Jill Weissberg-Benchell Journal: J Pediatr Psychol Date: 2018-06-01
Authors: Barbara J Anderson; Sharon Edelstein; Natalie Walders Abramson; Lorraine E Levitt Katz; Patrice M Yasuda; Sylvia J Lavietes; Paula M Trief; Sherida E Tollefsen; Siripoom Vudhipoom McKay; Patricia Kringas; Terri Lynn Casey; Marsha D Marcus Journal: Diabetes Care Date: 2011-08-11 Impact factor: 19.112
Authors: Agnieszka Butwicka; Louise Frisén; Catarina Almqvist; Björn Zethelius; Paul Lichtenstein Journal: Diabetes Care Date: 2015-02-03 Impact factor: 19.112
Authors: Robert P Hoffman; Cecilia P Damilano; K Ming Chan Hong; Bethany A Glick; Manmohan K Kamboj Journal: Acta Diabetol Date: 2022-06-01 Impact factor: 4.280